Literature DB >> 24487701

Repetitive transcranial magnetic stimulation in restless legs syndrome: preliminary results.

Burcu Altunrende1, Serpil Yildiz, Ayse Cevik, Nebil Yildiz.   

Abstract

Our aim was to compare the effect of high-frequency repetitive transcranial magnetic stimulation (rTMS) over supplementary motor area with that of sham stimulation in restless legs syndrome (RLS). In this prospective study, patients were randomly assigned to either real stimulation group (11 patients), or sham stimulation group (8 patients) in a double-blinded fashion. Five patients, who were initially in the sham stimulation group, received real stimulation 1 month after the sham stimulation. One session of intervention was performed once every 3 days and total of ten sessions were done in each group. The International RLS-Rating Scale (IRLS-RS) was assessed at baseline and after 5th and 10th sessions in both groups and also in five patients in whom both sham and real stimulation were performed. A statistically significant difference was seen in the IRLS scores between real (n = 11) and sham stimulation (n = 8) after 5th and 10th sessions. The real stimulation significantly improved the IRLS-RS scores although they were unaffected by the sham stimulation. In five patients, in whom both sham and real stimulation were performed, a statistically significant improvement was seen in the IRLS-RS scores with the real stimulation and a statistically significant difference was seen in the IRLS scores between real and sham stimulation after 10th session. In conclusion, this method is safe and non-invasive, and the results of this pilot study may support that rTMS has the potential to be used in the treatment of RLS, which should be verified in larger series.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24487701     DOI: 10.1007/s10072-014-1653-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  26 in total

1.  Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.

Authors:  N Turjanski; A J Lees; D J Brooks
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

Review 2.  Is there a future for therapeutic use of transcranial magnetic stimulation?

Authors:  Michael C Ridding; John C Rothwell
Journal:  Nat Rev Neurosci       Date:  2007-07       Impact factor: 34.870

3.  Therapeutic effect of repetitive transcranial magnetic stimulation on motor function in Parkinson's disease patients.

Authors:  E M Khedr; H M Farweez; H Islam
Journal:  Eur J Neurol       Date:  2003-09       Impact factor: 6.089

4.  Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding.

Authors:  Simon Cervenka; Sven E Pålhagen; Robert A Comley; Georgios Panagiotidis; Zsolt Cselényi; Julian C Matthews; Robert Y Lai; Christer Halldin; Lars Farde
Journal:  Brain       Date:  2006-07-01       Impact factor: 13.501

5.  Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson's disease.

Authors:  Eman M Khedr; John C Rothwell; Ola A Shawky; Mohamed A Ahmed; Ahmed Hamdy
Journal:  Mov Disord       Date:  2006-12       Impact factor: 10.338

6.  Placebo-controlled study of rTMS for the treatment of Parkinson's disease.

Authors:  Mikhail P Lomarev; Sulada Kanchana; William Bara-Jimenez; Meena Iyer; Eric M Wassermann; Mark Hallett
Journal:  Mov Disord       Date:  2006-03       Impact factor: 10.338

7.  Effects of motor cortex rTMS on lower urinary tract dysfunction in multiple sclerosis.

Authors:  D Centonze; F Petta; V Versace; S Rossi; F Torelli; C Prosperetti; St Rossi; G A Marfia; G Bernardi; G Koch; R Miano; L Boffa; E Finazzi-Agrò
Journal:  Mult Scler       Date:  2007-01-29       Impact factor: 6.312

8.  Chronic repetitive transcranial magnetic stimulation failed to change dopamine synthesis rate: preliminary L-[β-11C]DOPA positron emission tomography study in patients with depression.

Authors:  Yuko Kuroda; Nobutaka Motohashi; Hiroshi Ito; Shigeo Ito; Akihiro Takano; Hidehiko Takahashi; Toru Nishikawa; Tetsuya Suhara
Journal:  Psychiatry Clin Neurosci       Date:  2010-12       Impact factor: 5.188

9.  Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex.

Authors:  Antonio P Strafella; Tomás Paus; Maria Fraraccio; Alain Dagher
Journal:  Brain       Date:  2003-08-22       Impact factor: 13.501

10.  High-frequency rTMS over the supplementary motor area improves bradykinesia in Parkinson's disease: subanalysis of double-blind sham-controlled study.

Authors:  Masashi Hamada; Yoshikazu Ugawa; Sadatoshi Tsuji
Journal:  J Neurol Sci       Date:  2009-08-31       Impact factor: 3.181

View more
  4 in total

1.  Repetitive Transcranial Magnetic Stimulation for the Treatment of Restless Legs Syndrome.

Authors:  Yi-Cong Lin; Yang Feng; Shu-Qin Zhan; Ning Li; Yan Ding; Yue Hou; Li Wang; Hua Lin; Ying Sun; Zhao-Yang Huang; Qing Xue; Yu-Ping Wang
Journal:  Chin Med J (Engl)       Date:  2015-07-05       Impact factor: 2.628

2.  Brain regions associated with periodic leg movements during sleep in restless legs syndrome.

Authors:  Tae-Joon Kim; Kwang Su Cha; Sanghun Lee; Tae-Won Yang; Keun Tae Kim; Byeong-Su Park; Jin-Sun Jun; Jung-Ah Lim; Jung-Ick Byun; Jun-Sang Sunwoo; Jung-Won Shin; Kyung Hwan Kim; Sang Kun Lee; Ki-Young Jung
Journal:  Sci Rep       Date:  2020-01-31       Impact factor: 4.379

3.  Clinical and electrophysiological impact of repetitive low-frequency transcranial magnetic stimulation on the sensory-motor network in patients with restless legs syndrome.

Authors:  Giuseppe Lanza; Mariagiovanna Cantone; Debora Aricò; Bartolo Lanuzza; Filomena Irene Ilaria Cosentino; Domenico Paci; Maurizio Papotto; Manuela Pennisi; Rita Bella; Giovanni Pennisi; Walter Paulus; Raffaele Ferri
Journal:  Ther Adv Neurol Disord       Date:  2018-02-26       Impact factor: 6.570

4.  Nonpharmacological therapies for central poststroke pain: A systematic review.

Authors:  Xiao-Min Xu; Hua Luo; Ben-Bing Rong; Xiao-Mei Zheng; Feng-Tao Wang; Shu-Jiang Zhang; Zuo-Xiao Li
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.